Replies to post #90597 on Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

The word is getting out to the market about the tremendous potential that the company has with LymPro and MANF. The company is substantially undervalued. Just ask Jason Napadano.

I still believe that 99% of the individuals that will own shares in AMBS two years from now still haven't heard about the company.

Anyone buying shares today is getting in at the bottom.

All IMHO.

Twitter: @AmarantusBio